Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo. Reduced incidence of myopia and myopic shift after 2 years of follow-up was seen in patients who ...

Low-concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ.

Please provide your email address to receive an email when new articles are posted on . Both 0.03% and 0.05% atropine eyedrops significantly enlarged pupil size. Low-dose atropine drops had no ...

Children who took short-term topical atropine eye drops, 0.01% to 1.0%, had no difference in final refractive errors 10 to 20 years after treatment. Taking short-term topical atropine eye drops, with ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

Low concentration atropine eye drops are a safe and effective treatment for short-sightedness (myopia) in UK children, although the effects are small, suggests a clinical trial published by The BMJ ...

Atropine eye drops more effective than placebo for reducing myopia progression, with no differences seen in subgroup analysis. HealthDay News — Low-concentration atropine eye drops significantly ...

Share on Pinterest Experts say the incidence of nearsightedness in children is rising. Catherine Falls Commercial/Getty Images Experts say that developing nearsightedness as a child might be an ...

Low-dose atropine eye drops modestly slowed the progression of myopia in children according to a randomized placebo-controlled trial published in The BMJ. The findings add to growing evidence ...

Please provide your email address to receive an email when new articles are posted on . The dual therapy group experienced a reduction in tear breakup time and greater corneal epithelial thinning.